EmVenio

What happens when a key vendor can no longer support your trial? The best sponsors don't just need a replacement vendor. They need a partner that can protect momentum. With 20+ years of experience, we have the operational expertise to rapidly deploy, transition services, and rescue trials with minimal disruption to patients, sites, and study timelines. Read more: https://hubs.ly/Q04ygqH-0

We're excited to officially welcome you to EmVenio's research center at Prime Healthcare's Saint Mary of Nazareth Hospital in Chicago! Please join us at our open house to check out the new space and meet the research team. We hope to see you there! #openhouse #sitenetwork #researchsite #clinicalresearch

It’s been two months since we introduced EmVenio to the world. This wasn’t just a name change—it was a bold step forward in how we show up for sponsors, CROs, and the communities we serve. EmVenio means REACH. And that’s exactly what we’re delivering: Proactive partnerships that help sponsors stay ahead of study timelines, inclusive access that brings trials directly to patients, wherever they are and operational excellence that turns complexity into clarity. We’re proud of what this brand represents—and even more proud of the people behind it. The energy, collaboration, and purpose driving EmVenio are already making an impact. If you haven’t seen the story behind our rebrand, I invite you to take a look: https://lnkd.in/dMhzbTCb #EmVenio #ClinicalResearch #AccessMatters #Rebrand

It’s been two months since we introduced EmVenio Clinical Research to the world. This wasn’t just a rebrand—it was a reflection of who we’ve become and the impact we’re committed to making in clinical research. Reach isn’t just a word we use—it’s built into our name. At EmVenio, we’re helping sponsors and CROs be more proactive by bringing clinical trials directly to the communities that need them most. That means faster timelines, more inclusive data, and a better experience for everyone involved. I’m proud of the team behind this transformation and energized by the momentum we’re seeing. If you haven’t seen the story behind EmVenio, I invite you to take a look: https://lnkd.in/gKgx94JS #EmVenio #ClinicalResearch #AccessMatters #Rebrand

Two months ago, we introduced EmVenio Clinical Research—a name that reflects both our evolution and our purpose. As a physician and researcher, I’ve seen firsthand how access can shape outcomes. At EmVenio, we’ve built a model that brings clinical trials directly to communities—making research more inclusive, more proactive, and more representative of the real world. Reach isn’t just part of our mission—it’s built into our name. And it’s what enables sponsors and CROs to move faster, engage smarter, and deliver better results. I’m proud to be part of a team that’s not just talking about change—we’re delivering it. Learn more about the story behind EmVenio: https://lnkd.in/ep9RNFHD

The energy was real—and the conversations were powerful. At the 2025 SCRS Global Site Solutions Summit, we were proud to be part of a community pushing clinical research forward. From packed panels to meaningful moments, our team felt the momentum around making trials more human and more accessible. 📍 Missed it? Catch the highlights and hear what resonated most 👉 Read the recap: https://hubs.ly/Q03Pp4HV0 #SCRS2025 #ClinicalResearch #SiteSolutions #EmVenio